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Interactions between the key regulatory genes of the cardiogenic pathway, including those from the GATA and Nkx2
transcription factor families, are not well defined. Treating neurula-stage Xenopus embryos with retinoic acid (RA) causes
a specific block in cardiomyocyte development that correlates with a progressive reduction in the region of the presumptive
heart-forming region expressing Nkx2.5. In contrast, RA does not block expression of the GATA-4/5/6 genes, which are
transcribed normally in an overlapping pattern with Nkx2.5 throughout cardiogenesis. Instead, GATA-4/5/6 transcription
levels are increased, including an expansion of the expression domain corresponding to lateral plate mesoderm that is part
of the early heart field, but that normally is progressively restricted in its ability to contribute to the myocardium.
GATA-dependent regulatory sequences of the Nkx2.5 gene that implicate GATA-4/5/6 as upstream positive regulators were
described recently. However, our experiments also indicate that GATA factors might normally antagonize transcription of
Nkx2.5. To test this hypothesis we generated a dominant negative isoform of GATA-4 (SRG4) capable of inhibiting
transcription of GATA-dependent target genes. Ectopic expression of SRG4 results in a transient expansion of the Nkx2.5
transcript pattern, indicating that a normal function of GATA factors is to limit the boundary of the Nkx2.5 expression
domain to the most anterior ventral region of the heart field. Regulatory mechanisms altered by excess RA must function
normally to limit GATA-4/5/6 expression levels, to define the region of Nkx2.5 expression and regulate myocardial
differentiation. © 1999 Academic PressKey Words: GATA factors; tinman; cardiogenesis; Xenopus; embryogenesis.
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cINTRODUCTION
The vertebrate heart develops from bilateral heart-
forming regions of lateral plate mesoderm, believed to be
specified before or during gastrulation (for review, see
Lyons, 1996; Mohun and Sparrow, 1997). Experiments in
Xenopus determined that signals from the organizer
(Sater and Jacobson, 1990b) and deep endoderm (Nascone
and Mercola, 1995) induce lateral mesoderm adjacent to
Spemann’s organizer to become heart. The exact nature
of this inductive signaling event is not known, although
bone morphogenetic proteins appear to play a significant
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All rights of reproduction in any form reserved.ole in initiating the cardiogenic program (Schultheiss et
l., 1997). Genes from two transcription factor families
re expressed during early development in overlapping
atterns within mesoderm and associated anterior
ndoderm of the presumptive heart-forming region. One
et of factors includes GATA-4/5/6 of the GATA family
f zinc finger-containing transcription factors (Jiang and
vans, 1996; Kelley et al., 1993; Laverriere et al., 1994)
nd the other is the Nkx2 (Csx) family of homeobox-
ontaining transcription factors (Evans et al., 1995; New-
an and Krieg, 1998; Tanaka et al., 1998; Tonissen et al.,
994) related to the Drosophila heart-specification gene
alled tinman (Bodmer, 1993).
The early coexpression of Nkx2 and GATA factors in theardiac crescent, prior to expression of known cardiomyo-
yte differentiation genes, is consistent with a model in
57
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58 Jiang, Drysdale, and Evanswhich members of both families cooperate in specifying or
otherwise regulating the development of cardiogenic pro-
genitors (Charron and Nemer, 1999; Evans, 1997). Both
subfamilies are implicated in regulating the expression of
multiple cardiac-specific genes (Grepin et al., 1994; Ip et al.,
994; Lyons et al., 1995; Molkentin et al., 1994) and may do
so by physical interaction within a common protein com-
plex (Durocher et al., 1997; Durocher and Nemer, 1998;
Sepulveda et al., 1998). The importance of Nkx2 and GATA
factors in heart development has been tested by loss-of-
function experiments. Expression of dominant-interfering
isoforms of Nkx2 proteins results in a complete block to
Xenopus heart development (Fu et al., 1998; Grow and
rieg, 1998). However, gene disruption experiments in mice
ave not demonstrated cell-specification functions for indi-
idual Nkx2 or GATA family members, but are instead
onsistent with critical roles in heart tube morphogenesis.
or example, disruption of Nkx2.5 leads to a nonlooping
eart tube phenotype (Lyons et al., 1995; Tanaka et al.,
999), and mutations in the human gene are identified as
ausing congenital heart disease (Schott et al., 1998). In the
ATA-4 null mutant mouse there is a failure of the two
eart primordia to fuse at the ventral midline, although
ardiac differentiation in the twinned bifid hearts that
evelop appears normal (Kuo et al., 1997; Molkentin et al.,
997). The primary abnormality of these mice is likely to be
efective endoderm development, leading by an unknown
echanism to failure in fusion of the two heart primordia
Narita et al., 1997). Some less obvious aspects of cardio-
yocyte differentiation may also be affected by the Nkx2.5
nd GATA-4 mutations, and additional roles in cardiomy-
cyte specification may be compensated by other family
embers.
In comparison to the Nkx2 family, for which there is
vidence of function in cardiomyocyte development
Cleaver et al., 1996), the genetic role for GATA factors
uring cardiogenesis appears relatively complex. GATA-4
as been demonstrated to have a positive effect on the
xpression of cardiac differentiation genes (Grepin et al.,
997), so that it would appear that different GATA factors
an have some nonoverlapping functions. Overexpression
f GATA-6 in Xenopus embryos was observed to block the
ifferentiation of heart precursors (Gove et al., 1997), sug-
esting that a decline in GATA-6 expression levels may be
cue for cardiomyocyte differentiation. In mice, GATA-6 is
equired for extraembryonic development and thus mice
acking this gene die before a potential role in cardiac
ifferentiation can be assessed (Koutsourakis et al., 1999;
orrisey et al., 1998), although GATA-6 mutant ES cells
re able to contribute to the heart in chimeric embryos.
owever, using antisense oligonucleotides, it is necessary
o deplete transcripts encoding each of the three chick
enes to detect cardiac abnormalities, indicating that all
hree GATA factors act in a common morphogenetic path-
ay (Jiang et al., 1998). Therefore, GATA factors may be
mportant for endoderm and mesoderm development re-
m
g
Copyright © 1999 by Academic Press. All rightated to cardiomyocyte proliferation and differentiation, as
ell as heart tube formation and morphogenesis.
Retinoids regulate an important signaling pathway for
ardiogenesis, and either an excess or a deficit of retinoic
cid (RA) is disruptive to normal heart development. Simi-
ar cardiogenic defects are caused by a lack of embryonic
etinoids (Zile, 1998) or if retinoid signaling is blocked
hrough targeted disruption of retinoid receptor genes (Gru-
er et al., 1996; Kastner et al., 1994; Lee et al., 1997; Luo et
l., 1996; Sucov et al., 1994). Retinoids may also be impor-
ant for the diversification of atrial and ventricular tissues
nd in the regulation of chamber-specific gene expression
Yutzey et al., 1994, 1995). The GATA-4 gene fails to be
xpressed in vitamin A deficient (VAD) quail embryos that
evelop an abnormal nonlooping heart tube, while Nkx2.5
xpression levels are not grossly affected (Kostetskii et al.,
999). These experiments link a requirement for retinoids
n establishment of a specific GATA-dependent cardiac
ranscriptional program associated with posterior heart
ube development and tube morphogenesis. In Xenopus,
ddition of RA blocks cardiac differentiation, even if ap-
lied after expression patterns for Nkx2 and GATA factors
re established (Drysdale et al., 1997). Transcript levels for
kx2.5, Nkx2.3 (Drysdale et al., 1997), and Nkx2.9 (P. A.
rieg, personal communication) decline rapidly in the
eart-forming region in response to RA exposure. The
ecline in transcripts encoding tinman-related genes may
e responsible for the block to cardiac differentiation.
lternatively, retinoic acid may be acting upstream of the
kx2 genes on a more general cardiac development pro-
ram. In this system RA is unlikely to be affecting cell
pecification because Xenopus heart specification is com-
leted by the end of gastrulation (Sater and Jacobson, 1989),
hile RA can affect heart differentiation of mid-neurula-
tage embryos.
Because the expression patterns of the Nkx2 and GATA
actors are largely overlapping during early cardiogenesis, it
s feasible that they might regulate the expression of each
ther; indeed the mouse promoter for Nkx2.5 has binding
ites for GATA factors and itself (Lien et al., 1999; Searcy et
l., 1998). There is evidence from the analysis of mouse
utations that cross-talk can occur between the GATA-4
nd the GATA-6 genes; meanwhile, Nkx2.5 is not required
or normal expression of GATA-4 (Tanaka et al., 1999). In
he Xenopus model, using retinoic acid to block expression
f Nkx2 expression and heart development allows us to test
f GATA factors are dependent on Nkx2 expression or are
oregulated by a common or linked signaling pathway. We
nd that GATA factors are not dependent on Nkx2.5 for
xpression, nor are GATAs sufficient for expression of
kx2.5 or for cardiac differentiation. Ectopic expression of
dominant negative GATA-4 confirms that GATA factors
ay normally restrict the expression domain of Nkx2.5 and
hat down-regulation of GATAs during neurula stages
ight be an important component of the normal cardio-
enic program.
s of reproduction in any form reserved.
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59Regulation of Nkx2.5 Transcript by GATA FactorsMATERIALS AND METHODS
Embryo and Explant Culture
Mature Xenopus females were injected with 700–800 IU of
uman chorionic gonadotrophin (Sigma) and the ovulated eggs
ere fertilized in vitro using minced testis. Embryos were dejellied
ith 2.5% cysteine, pH 8.0, and cultured in 20% Steinberg’s
olution or 0.13 MBS. Embryos were staged according to Nieuw-
oop and Faber (1967). Explants were isolated using fine forceps and
ultured in modified Danilchik’s medium (Peng, 1991) without
SA. Culture dishes were coated with a thin layer of 1% agarose.
Retinoic Acid Treatment
Retinoic acid (all-trans; Sigma) was prepared as a 1 mM stock
solution in dimethyl sulfoxide (DMSO). Embryos were immersed
in 1 mM retinoic acid at various embryonic stages and unless stated
he treatment was continuous. Control embryos were treated with
ml/ml DMSO.
RNA Analysis
Whole-mount in situ hybridization was performed as described
(Jiang and Evans, 1996). The Xenopus GATA-4/5/6 cDNA clones
used to generate the probes are also described (Jiang and Evans,
1996) and the xNkx2.5 probe is described in Tonissen et al. (1994).
he TnIc probe was prepared as described (Drysdale et al., 1994).
he xSox17a probe was a gift from the H. R. Woodland lab (Hudson
et al., 1997) and prepared following SmaI digestion using T7
polymerase. In some experiments, embryos were postfixed, washed
in water, dehydrated, washed twice in xylenes, and then infused
with paraplast overnight. After embedding, paraplast blocks were
trimmed and 10-m sections cut and floated onto “Superfrost Plus”
icroscope slides (Fisher), dried overnight, dewaxed in xylenes, and
overslipped using Permount (Fisher). Semiquantitative RT/PCR
o measure transcript levels of GATA-4 and EF-1a was performed
as described (Jiang and Evans, 1996) and quantified by phoshorim-
aging following gel electrophoresis.
Dominant Negative xGATA-4 (SRG4)
A region of the xGATA-4 cDNA encompassing both zinc
fingers and the entire DNA-binding domain (from amino acid
147 to 304) was isolated by PCR using primers that incorporated
a stop codon and permitted in-frame fusion at the N-terminus
with sequences encoding the strong repression domain (amino
acids 1– 69) of the mouse Mxi1 gene (Schreiber-Agus et al., 1995).
he Mxi1 cDNA was a gift from the R. DePinho laboratory. The
himeric cDNA encoding a protein called SRG4 was confirmed
y sequencing and then subcloned into vector pCDNA3, for both
n vitro transcription/translation and transfection experiments
n tissue-culture cells, and into vector pGEMHE (providing
lobin gene untranslated sequences) for in vitro transcription to
generate capped RNA for microinjection. For control experi-
ments, a near-identical cDNA was generated (mtSRG4) contain-
ing a single mutation of the SR domain (Mxi-SR-pro; a proline for
leucine substitution at amino acid residue 19 (Schreiber-Agus et
al., 1995)) that abolishes the ability of SR to interact with sin3 or
repress transcription. The SRG4 protein was tested for activity
using in vitro-generated rabbit reticulocyte lysates (Promega) by
gel mobility-shift experiments as described (Yang and Evans,
t
t
Copyright © 1999 by Academic Press. All right1992). Cotransfection experiments into QT6 fibroblasts were
performed and analyzed as described (Evans and Felsenfeld,
1991; Gao et al., 1998), using the GATA-4, SRG4, and mtSRG4
xpression plasmids and the aD3-luc and pCH110
b-galactosidase reporter plasmids. The aD3-luc reporter is iden-
ical to that described (Evans and Felsenfeld, 1991) except that
he CAT gene is replaced with a luciferase coding sequence
erived from pGL3basic (Promega). Each transfection contained
mg reporter, a total of 4 mg of expression vectors, and 0.25 mg
internal control reporter. For microinjection experiments,
capped mRNA was prepared in vitro from linearized pGEMHE/
SRG4 using a kit from Ambion. To determine the left/right
embryonic axis, fertilized eggs were tipped in medium contain-
ing 7% Ficoll and marked on the presumptive dorsal side using
Nile blue dye as described (Peng, 1991). At the eight-cell stage, a
single left dorsal/vegetal blastomere was injected with 4.5 nl of
solution containing 250 pg SRG4 RNA (or in control samples,
mtSRG4 RNA) in water containing 5 mg/ml fluorescein-dextran
(Molecular Probes; D-1820), to facilitate lineage tracing.
RESULTS
GATA-4/5/6 Transcription Is Not Inhibited in RA-
Treated Embryos That Fail to Express
Cardiomyocyte Markers
It was shown previously that treatment of Xenopus
embryos with 1 mM RA at stage 20 blocks differentiation of
he heart and causes a rapid loss of Nkx2.5 and Nkx2.3
ranscripts in the presumptive heart region. In contrast to
yocardial markers, endocardial development is apparently
esistant to this treatment, indicated by persistent expres-
ion of the X-msr gene (Drysdale et al., 1997). A superfi-
ially normal heart tube forms that fails to loop or form any
eating tissue. The loss of expression in the tinman-related
enes might be sufficient to explain the subsequent failure
o express markers of myocardial differentiation at later
tages, or it might reflect a more general loss of the
ardiovascular gene expression program. In the latter case, a
oss of GATA-4/5/6 expression in the RA-treated embryos
ight be predicted, given the overlapping expression pat-
erns of these two gene families throughout early cardio-
ascular development.
As shown in Fig. 1a, treatment of embryos at stage 20
ith 1 mM RA results in a near-complete loss of Nkx2.5 and
ardiac troponin I (TnIc) transcripts. The loss is complete in
any embryos, but the examples shown here indicate the
osition of the presumptive heart and illustrate an impor-
ant point. Treatment of embryos with RA does not dimin-
sh equally transcript levels throughout the heart-forming
egion. Rather, the spatial domain of transcripts is progres-
ively deleted toward the ventral midline, so that in many
ases only a small region of ventral tissue expresses Nkx2.5
nd a myocardial differentiation program. Note that Nkx2.5
ranscripts are detected readily in pharyngeal endoderm, an
nterior tissue that is not a normal expression domain for
ATA factors. In surprising contrast, we find that allhree GATA family members are expressed in the RA-
reated embryos and the domains of expression are even
s of reproduction in any form reserved.
ork
e pre
60 Jiang, Drysdale, and Evanssomewhat expanded. The patterns, as detected by whole-
mount in situ hybridization, are similar but not identical
for each of the three genes. In RA-treated embryos, the
FIG. 1. GATA-4/5/6 transcription is not inhibited by RA treatm
hybridization was performed using probes specific to transcripts fo
Embryos are oriented with anterior to the left, dorsal to the top. RA
35. Examples of control embryos, treated with DMSO alone, are sh
arrow and arrowheads in the two upper right images indicate the sm
at the most ventral position of the presumptive heart-forming r
GATA-4/5/6, remains positive for Nkx2.5 following RA treatmen
RA-treated embryo due to extended staining in order to observe th
Nkx2.5 RNA are not observed generally in pharyngeal endoderm
RA-treated embryo analyzed for xGATA-6 RNA to illustrate the
activation is seen for GATA-5 but not for GATA-4. Our previous w
(Gao et al., 1998), and so this domain is likely to correspond to thpatterns extend more broadly dorsal and caudal relative
to control embryos. The expanded domain that encom-
Copyright © 1999 by Academic Press. All rightpasses the GATA-4/5/6 pattern does not correspond in
any obvious manner to a specific tissue. For both
GATA-5 and GATA-6, there was in addition ectopic
which blocks myocardial differentiation. (a) Whole-mount in situ
diac troponin I, Nkx2.5, or GATA-4/5/6, as indicated on the right.
added at stage 23 and embryos were allowed to develop until stage
on the left; examples of RA-treated embryos are on the right. The
atch of differentiated myocardium that remains in these embryos,
. Note that the pharyngeal endoderm, which does not express
e Nkx2.5 levels appear increased in pharyngeal endoderm of this
k signal in the residual heart region. However, enhanced levels of
A-treated embryos (Drysdale et al., 1997). (b) An example of an
uction of a posterior domain of transcription (arrow). A similar
implicated GATA-6 in the regulation of progenitor cells of the gut
sumptive hindgut.ent,
r car
was
own
all p
egion
t. Th
e wea
of R
indexpression of transcripts detected around the developing
hindgut (Fig. 1b).
s of reproduction in any form reserved.
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62 Jiang, Drysdale, and EvansRA-Treated Embryos Maintain both Mesodermal
and Endodermal Expression of GATA Factors
GATA-4/5/6 are expressed normally in both the precar-
diac mesoderm and the associated endoderm of the pre-
sumptive anterior foregut. Therefore, the expression of
GATA factors in RA-treated embryos might reflect a rela-
tive expansion of the endodermal expression domain rela-
tive to the presumptive myocardium. To characterize fur-
ther the transcript patterns for xGATA-4/5/6, RA-treated
and control embryos were sectioned following whole-
mount in situ hybridization. As shown in Fig. 2a (sagittal
ections), transcripts of xGATA-4/5/6 persist in the un-
olded layer of tissue that would normally have formed
ifferentiated myocardium and the endocardium of the
A-treated embryos. Expression in the persisting endocar-
ial layer as well as the closely associated anterior
ndoderm is more easily analyzed in cross section, as
hown for example with GATA-4 in Fig. 2b. Similar pat-
erns were found for GATA-5 and GATA-6 (not shown).
Early Exposure to RA Further Enhances GATA-4
Expression in the Complete Absence of Anterior
Structures
When retinoic acid is applied to Xenopus embryos at the
end of neurulation, it affects specifically the developing
heart region while the rest of the embryo is relatively
normal. Although there is no detectable myocardial-
specific gene expression, there is limited cardiac morpho-
genesis (Drysdale et al., 1997). When retinoic acid is applied
prior to gastrulation, there is a general loss of all anterior
structures including heart (Durston et al., 1989; Sive et al.,
1990). This complicates interpreting a direct relationship
between the addition of retinoic acid at early stages and
cardiac development, but does allow us to determine
FIG. 2. GATA-4/5/6 transcription is maintained and enhanced in b
sections taken from embryos analyzed first by whole-mount in situ
riented as in Fig. 1; the cement gland is visible as brown tissue
MSO-treated embryos are shown on the left; samples from RA-tr
ndicated on the left. The myocardial (arrowhead) and associated
ndicated on the right. (b) Cross section of a similarly treated embry
EC) layer is indicated for both control (top) and RA-treated (lower
IG. 3. Earlier treatment of embryos with RA results in further e
and are oriented) as in Fig. 1a (except that the embryos were fixe
ontinuous treatment of RA added at stage 10.5 (top), stage 14 (2n
ontrols treated only with DMSO. Even in embryos with anterior tr
ateral plate. GATA-5 and GATA-6 were also transcribed in these e
ross sections are shown of embryos treated with RA beginning at
he control embryos (left), the GATA-4 transcript pattern is enhan
dentity of the endoderm layer, embryos were also analyzed for t
treatment (not shown). Sections were taken either from an anterior (
proper (bottom). (c) Embryos were treated with RA from stage 10.
equivalent of stage 30 (right lanes) and analyzed for GATA-4 or control
ith the signals detected by in situ hybridization, the steady-state tran
Copyright © 1999 by Academic Press. All rightwhether the persistent expression of GATA factors is de-
pendent on the initial presence of a cardiogenic program.
We examined embryos exposed continuously to 1 mM RA
starting at gastrulation (stage 10.5) or at midneurula (stage
14/15) and compared development and expression patterns
with control embryos and those treated at stage 20. In
embryos treated early we obtained the expected axis defects
and general loss of anterior structures. In those embryos,
the expression of GATA-4/5/6 genes, particularly GATA-4,
is not only detected at the anterior ventral region, but also
expanded to the dorsoanterior boundary (Fig. 3a), while
Nkx2.5 transcripts are not detected. Examination of sec-
tions from the embryos reveal that the GATA transcripts
are present in the presumptive mesoderm and the associ-
ated endoderm cells, similar to the pattern in control
embryos but enhanced. This is particularly obvious in the
case of GATA-4, as shown in Fig. 3b. We used a probe to the
endoderm marker Sox17a (Hudson et al., 1997) to demon-
strate that endoderm and mesoderm are both still present in
the RA-treated embryos and that GATA-4 transcripts per-
sist clearly in the mesoderm layer (Fig. 3b). To further
confirm that RA treatment results in an increase in the
transcript levels of GATA-4, embryos were exposed to
continuous RA treatment from stage 10.5, either for 4 h or
to stage 30; RNA was isolated and assayed for GATA-4
transcripts by semiquantitative RT/PCR. In either case, the
levels of GATA-4 transcripts are increased twofold in the
RA-treated embryos relative to the control embryos (Fig.
3c).
A Dominant Negative Form of xGATA-4 Can
Inhibit the Activation of GATA Target Genes
Our observation that expression levels of xGATA-4/5/6
genes are increased by RA treatment while the Nkx2.5 gene
is coordinately inactivated leads to the unexpected possi-
he mesoderm and the endoderm of RA-treated embryos. (a) Sagittal
ridization for Nkx2.5 or GATA-4/5/6 (top to bottom). Embryos are
acent to the Nk in the upper left image). Sections from control
embryos are on the right. The position of the folded heart (ht) is
derm layer (En), both of which are positive for GATA-4/5/6, are
lyzed for GATA-4 transcripts. Dorsal is to the top. The endocardial
ples.
sion of the GATA-4 transcript pattern. (a) Embryos were analyzed
tage 30) for GATA-4 (left) or Nkx2.5 (right) transcripts following
m top), or stage 20 (3rd from top). Embryos on the bottom were
tions the GATA-4 gene is transcribed in an expanded region of the
os, but did not show such an obvious expansion of the pattern. (b)
e 10.5 and analyzed for GATA-4 transcripts as in (a). Compared to
nd expanded in the RA-treated embryos (middle). To confirm the
ripts from the Sox17a gene. This pattern was unaffected by RA
sition (top) or from a more posterior (P) position caudal to the heart
RNA was harvested from embryos after 4 h (left lanes) or at theoth t
hyb
(adj
eated
endo
o ana
) sam
xpan
d at s
d fro
unca
mbry
stag
ced a
ransc
A) po
5 andEF-1a transcript levels by semiquantitative RT/PCR. Consistent
script levels for GATA-4 were increased 100% by RA treatment.
s of reproduction in any form reserved.
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63Regulation of Nkx2.5 Transcript by GATA Factorsbility that GATA genes and the Nkx2.5 gene might have
some functions in cardiogenesis that are antagonistic. To
further investigate the genetic relationship between GATA
genes and Nkx2.5, a dominant negative form of GATA-4
was generated (SRG4, Fig. 4a) by fusing the “strong repres-
sion” (SR) domain of the murine Mxi1 protein to the
amino-terminus of a peptide encompassing the DNA-
binding domain from GATA-4 (G4). The SR domain of
Mxi1 interacts with the general chromatin repressor pro-
tein sin3 to mediate suppression of myc oncogenic activity
(Schreiber-Agus et al., 1995). It has been shown that when
used to a heterologous DNA-binding domain, the SR
omain can target sin3 to gene-specific binding sites leading
o repression (Harper et al., 1996). A mutant form of SRG4
(mtSRG4) was also generated, containing a single amino
acid alteration of the SR domain that abolishes interaction
with sin3 and is unable to repress transcription.
The SRG4 (and the mtSRG4; not shown) bind specifically
to a consensus GATA-binding cis-element (Fig. 4b). The
ability of the SRG4 construct to suppress transcription
directed by GATA-4/5/6 was tested in a cell culture system.
In this study, each of the three cardiac GATAs trans-
activates a model GATA-dependent reporter gene approxi-
mately eightfold (an example is shown for GATA-4 in Fig.
4c). Coexpression of SRG4 in the transfection assay com-
pletely suppresses the trans-activation, even below the
basal level. In the experiment shown, the SRG4 expression
vector is in threefold excess over the GATA-4 expression
vector, but suppression to basal level is found even using
equal ratios (not shown). Coexpressed SRG4 was equally
capable of suppressing activation of the reporter by GATA-5
and GATA-6 (not shown). In contrast, the control mtSRG4
was unable to inhibit activation by wild-type GATA-4 (Fig.
4c). Similar results were found for a protein consisting of
the DNA-binding domain of GATA-4 alone; if expressed in
further excess this protein or the mtSRG4 protein could
inhibit coexpressed wild-type GATA-4 activity only about
twofold (not shown). Therefore, SRG4 can function as a
dominant negative isoform by competing with wild-type
GATA factors to inhibit activation of GATA-dependent
targets.
Expression of SRG4 Expands the Posterior
Expression Domain of the Nkx2.5 Gene during
Early Stages of Cardiogenesis
Our data using exogenous RA treatment correlated in-
creased expression of GATA factors with inhibition of
Nkx2.5. If this represents a genetic interaction, a prediction
can be made that decreasing GATA factor activity might
result in enhanced expression of Nkx2.5. To inhibit GATA-
dependent gene expression in vivo, in vitro-transcribed
RG4 mRNA was injected into a left dorsal–vegetal blas-
omere of eight-cell-stage embryos. According to the fate
ap (Moody, 1987), the dorsal–vegetal blastomeres contrib-te to the future heart. In control experiments, RNA
ncoding mtSRG4 was injected. The injected embryos were
Copyright © 1999 by Academic Press. All rightssayed by whole-mount in situ hybridization at stage
6/27 for the transcription of Nkx2.5, just prior to fusion of
he two bilateral primordia at the ventral midline. As
hown in Fig. 5a, the Nkx2.5 transcript pattern is seen in
ontrol (lacZ injected) embryos in symmetric patches of
resumptive heart myocardium, as well as pharyngeal
ndoderm. In 42% of the embryos injected with SRG4
NA, an asymmetric Nkx2.5 transcription pattern was
etected (64/152, compared to 2% of the mtSRG4-injected
mbryos; see Table 1). This expanded domain of expression
as not seen when embryos were injected with other
NAs, including those encoding full-length GATA-4. Of
he embryos with asymmetric expression (estimated visu-
lly as having one side roughly twice or more the area of the
ther), the expanded pattern was detected in 80% of the
ases on the presumed injected (left) side. Analysis of
o-injected lineage tracer confirmed that the accuracy of
argeting RNA to the left dorsal–vegetal blastomere was
5%. The expanded domain of Nkx2.5 transcripts is re-
tricted to mesoderm and is located primarily in a domain
ore posterior to that found in normal embryos (Fig. 5b).
The embryos injected with either SRG4 or mtSRG4
enerally went on to develop without obvious abnormali-
ies. The expression of SRG4 is for technical reasons tran-
ient and is presumably overcome by normal expression of
ATA factors in the developing cardiovascular region. It is
ot surprising that the hearts of SRG4 embryos are normal,
iven the regulative ability of Xenopus embryos to control
heart size. We attempted to increase the amount of SRG4
by targeting both sides of the developing heart. Unfortu-
nately, injection into both dorsal/vegetal blastomeres at the
eight-cell stage results in severe phenotypic abnormalities
in a high percentage of embryos that complicated further
analysis of cardiogenesis (short, stubby embryos displaying
an expanded “pigeon chest,” but with no consistent heart
phenotype). We conclude that inhibition of GATA-
dependent gene expression leads to ectopic Nkx2.5 tran-
scription, consistent with a normal function for GATA
factors in regulating the Nkx2.5 expression domain.
DISCUSSION
GATA-4/5/6 Expression Is Enhanced in Response
to Retinoic Acid, Concurrent with Decreased
Transcription of Nkx2.5 and a Failure in
Cardiomyocyte Differentiation
The phenotype of the neurula-stage RA-treated embryo is
a strikingly specific defect in Nkx2 gene expression and a
block to myocardial differentiation. Given the overlapping
coexpression of GATA and Nkx2 family members through-
out early stages of heart development, it might be predicted
that these embryos would have a similar defect in GATA
factor expression. However, transcription of GATA-family
members is activated, rather than inhibited, by retinoid
signaling (Arceci et al., 1993; Boylan et al., 1995; Kostetskii
s of reproduction in any form reserved.
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65Regulation of Nkx2.5 Transcript by GATA FactorsFIG. 5. Ectopic targeted expression of SRG4 results in an expanded pattern of Nkx2.5 transcription. Examples are shown of embryos
injected at the 8-cell stage into one left-side dorsal–vegetal blastomere with RNA encoding control LacZ RNA, mtSRG4, or SRG4, as
indicated. Embryos were fixed at stage 26 and analyzed by whole-mount in situ hybridization for Nkx2.5 transcripts; processed embryos
are viewed from the ventral side, anterior is up. The control embryo is slightly older so the right (R) and left (L) sides of the primitive heart
tube are fusing at the midline. Compared to the symmetric pattern seen here or in the prefusing primordia of the mtSRG4-injected embryo,
the SRG4-injected embryos display an expanded domain of Nkx2.5 transcription in the left primordium (arrows). (b) An embryo injected
in the left blastomere with SRG4 RNA was processed as in (a), and sections were taken through the region of the fusing primordia. Shown
are four sections taken from progressively more posterior regions (left to right). Note that in the most anterior regions the Nkx2.5 pattern
is not significantly changed, but left-side enhanced transcripts are detected in more posterior sections (arrows).
FIG. 4. SRG4 functions as a dominant negative isoform capable of inhibiting activation of GATA-4 targets. (a) Schematic illustration of
the domain structure of SRG4. The strong repression (SR) domain of Mxi.1 is fused to a region of GATA-4, containing both zinc fingers (cc
cc), that constitutes the DNA-binding and cofactor interaction domains of GATA-4. A control isoform (mtSRG4) was also generated,
containing a single amino acid change (leucine to proline, p) that abolishes the ability of SR to repress gene expression. SRG4 is predicted
to repress GATA-dependent target genes through interaction with normal GATA-binding sites containing a WGATAR consensus sequence.
(b) A gel mobility-shift experiment demonstrates that SRG4 binds with specificity to a consensus GATA cis-element. The GATA-binding
probe (P) was end-labeled and incubated with rabbit reticulocyte lysate charged with in vitro-generated RNA encoding SRG4. The reaction
included no competitor (0) or a 50-fold molar excess of unlabeled oligomer containing the same specific (sp) binding site or a similar
oligomer containing a mutation (mt) of the GATA motif. (c) A well-characterized GATA-dependent reporter (aD3-luc) was cotransfected
into QT6 fibroblasts with (1) or without (0) a GATA-4 expression vector, along with an empty vector (to maintain total amount of vector
DNA), mtSRG4, or SRG4 as indicated. The level of activation relative to the basal promoter activity is shown after normalizing for activity
of a cotransfected b-galactosidase reporter that is not regulated by GATA-4 expression. The results shown are from three independent
xperiments, each performed in duplicate; red stacked bars represent standard deviation. SRG4 was equally capable of repressing activation
y xGATA-5 or xGATA-6 (not shown).
Copyright © 1999 by Academic Press. All rights of reproduction in any form reserved.
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66 Jiang, Drysdale, and Evanset al., 1999; Soudais et al., 1995). Regulation of retinoid
ignaling is a conserved component of normal cardiogenesis
nd excess RA present during pregnancy or administered
irectly to embryos or precardiac fields causes severe car-
iac abnormalities, including cardia bifida (Hoffman and
ichele, 1994; Smith and Dickman, 1997). Although many
tudies have documented changes in cardiomyocyte devel-
pment in the presence of excess retinoids, these results
ust be interpreted with caution because it is not yet
stablished that the phenotypes are related mechanistically
o normal development. In our studies regarding the influ-
nce of exogenous RA on the regulation of Nkx2.5 and
ATA factors, we feel that the results are likely to be of
elevance for several reasons:
First, the phenotype is specific to the developing heart
n embryos that appear otherwise quite normal, so the
ffect is unlikely to be derived from an indirect terato-
enic response, for example, as seen when early treated
mbryos show a general loss of anterior structures, in-
luding the heart. The phenotype is seen when embryos
re treated at the neurula stage, long after specification
nd axis patterning is thought to be finished. Second, the
henotype is consistent (and opposite) to that seen in
ice with targeted disruptions in retinoic acid receptor
enes (Kastner et al., 1997). These mutant mice display
efective cardiac morphogenesis with a thin myocardium
ttributed to precocious ventricular cardiomyocyte dif-
erentiation. Therefore, a lack of retinoid signaling accel-
rates differentiation, while in our studies excess retin-
ids block differentiation. Finally, and most importantly,
he expression patterns for GATA-4 and Nkx2.5 follow-
ng RA treatment are exactly what would be predicted
TABLE 1
Injected mRNA
Total no.
embryos injected Left . right Right . left
SRG4 mRNA 152 51 (33.6%) 13 (8.6%)
mtSRG4 RNA 106 2 (1.9%) 0
Note. Embryos were injected at the 8-cell stage in a single left
dorsal–vegetal blastomere with 250 pg of RNA encoding either
SRG4 or mtSRG4. Embryos were fixed at stage 26 and analyzed for
Nkx2.5 transcripts as shown in Fig. 5. Left . right indicates
embryos with an expanded domain of Nkx2.5 on the left heart
primodium, prior to fusion; 2 such embryos are shown for example
in Fig. 5a. To determine the accuracy of targeting, 244 embryos
were analyzed by fluorescence microscopy before being fixed for
the co-injected dextran tracer. In this case, 183 (75%) were FITC-
positive primarily on the left side. The other embryos were injected
mistakenly on the right side, or the analysis was complicated by
cell mixing. The lineage tracing results indicate that the 13
SRG4-injected embryos showing a right . left pattern can be
explained by mistargeting of the injected RNA.ased on our analysis of the vitamin A-deficient quail
mbryo, completely lacking in embryonic retinoid signal-
Copyright © 1999 by Academic Press. All rightng. This embryo, which has a differentiated myocardium
ut a severe heart tube morphogenetic defect, fails to
xpress GATA-4, while Nkx2.5 transcripts are still
resent. Therefore, in the absence of RA the GATA-4
ene is off and the Nkx2.5 is on, while in the presence of
xcess RA the GATA-4 transcript pattern is enhanced
nd the Nkx2.5 gene is turned off. Retinoic-responsive
lements in the Nkx2.5 gene are not described. Our data
mplicate GATA factors as an intermediary and are
onsistent with a normal function for RA in regulating
he embryonic expression pattern of GATA factors with
elevance to the developing cardiovascular system.
GATA Factors May Function Upstream of Nkx2,
but Are Not Sufficient in the Absence of Nkx2
Expression to Direct Cardiomyocyte Development
Transcripts for GATA-4/5/6 can be detected faintly as
early as stage 3 in gastrulating cells of the chick primitive
streak that include the cardiogenic progenitors. Although
it is not known if functional protein is expressed this
early, by the cardiac crescent stage transcripts for all
three genes are detected readily in largely overlapping
patterns throughout a broad region of lateral plate meso-
derm and associated endoderm, in cells that eventually
generate (among other things) endocardium, myocar-
dium, great vessel endothelia, and foregut endoderm.
This early pattern of GATA factor expression therefore
marks cells that contribute generally to the cardiovascu-
lar system, while part of the Nkx2.5 pattern is overlap-
ping, within those progenitors that will form the myo-
cardium. Our results suggest that the observed changes in
GATA expression may play a role in the loss of Nkx2.5
expression in the presumptive heart region. As the exog-
enous RA is able to block the differentiation of the heart,
it would suggest that GATA factors alone are unable to
allow cardiac differentiation and thus implicate Nkx2
family members as playing an essential role in this
process. There is no direct evidence from mouse muta-
tional studies that GATA factors regulate Nkx2 family
members or vice versa. However, these analyses are
complicated by likely functional redundancy among fam-
ily members. Indirect evidence that GATA factors func-
tion upstream of and regulate the expression of Nkx2.5
comes from transgenic mouse experiments that deter-
mined functionally relevant enhancer sequences of the
Nkx2.5 gene that contain GATA binding sites (Lien et
al., 1999; Searcy et al., 1998). These experiments indicate
that activation of the Nkx2.5 gene in presumptive cardi-
omyocytes is dependent on GATA factors. If this were a
direct epistatic relationship we would predict that ex-
pression of a dominant negative GATA-4 isoform might
reduce Nkx2.5 transcript levels. Instead the opposite
result was obtained; the pattern of Nkx2.5 was expanded
in a significant fraction of the embryos, particularly along
the ventral/caudal midline, in cells that do not normally
contribute to the myocardium.
s of reproduction in any form reserved.
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67Regulation of Nkx2.5 Transcript by GATA FactorsAlthough this result may appear counterintuitive, it is
entirely consistent with the expression of Nkx2.5 when
GATA factor activity is affected by alterations in retinoid
signaling. Therefore, increased expression of GATA fac-
tors in the RA-treated Xenopus embryos correlates with
decreased transcription of Nkx2.5. Similarly, depletion of
GATA factors in the VAD embryo does not lead to a lack
of Nkx2.5. The transcript levels for Nkx2.5 in the VAD
quail were not quantified, but we predict that they might
even be enhanced in the GATA-4-deregulated embryos.
In this case an argument for functional compensation of
Nkx2.5 expression by GATA-6 is unlikely, because
GATA-6 transcripts are also decreased in the VAD em-
bryo, albeit less dramatically relative to GATA-4. A
simple hypothesis that is consistent with our data in
RA-treated frog embryos, the VAD quail embryo, the
SRG4-injected frog embryos, and the transgenic mouse
experiments is that GATA factors regulate the expression
of Nkx2.5 but can do so in either a positive or a negative
manner, depending on the cell context. Therefore, in
presumptive cardiomyocytes, GATA factors might acti-
vate or maintain the expression of Nkx2.5, while in
regions of the embryo posterior and lateral to the myo-
cardial progenitors (for example, in the region of the
developing inflow tract) GATA factors might inhibit the
Nkx2.5 gene. This differential regulation by GATA fac-
tors could be important either in defining the myocardial
subpopulation or in patterning of the developing heart
tube along the anterior/posterior axis. Currently, the
mechanism for differential regulation of Nkx2.5 can only
be speculated, but could involve cell- or region-specific
cofactors different levels of specific GATA factors, or
posttranslational modification of specific GATA factors.
Perhaps most interesting, the GATA cofactor FOG-2
mediates either activation or repression of GATA-
dependent promoters, depending on the gene and the cell
type tested (Lu et al., 1999; Svensson et al., 1999). This is
precisely the type of mechanism that could lead to
differential regulation of Nkx2.5 by GATA factors in the
developing heart.
A Potential Role for GATA Factors in Regulating
the Boundaries of the Precardiac Field
The concept of a heart morphogenetic field refers to
that region of the embryo that is capable of contributing
to the developing heart, including progenitors that do not
normally do so. The presence and boundary of a field can
be determined experimentally in explant assays (that
presumably relieve some cells of the field from negative
regulatory mechanisms that normally restrict cardiac
differentiation) or in cell-ablation experiments (in which
additional cells of the field are redirected to a heart cell
fate by unknown regulatory mechanisms to compensate
for those that are lost). For example, explant assays that
scored for the presence of beating heart tissue showed
that in Xenopus neurula embryos (stage 20) the area that
r
h
Copyright © 1999 by Academic Press. All rightan form heart tissue includes anterior ventral and ven-
rolateral mesoderm (Sater and Jacobson, 1990a). By stage
8 the field is restricted to the anterior ventral meso-
erm. The molecular basis of how a heart field is re-
tricted has until recently been elusive. However, we
ote that the expanded domain of GATA factor expres-
ion seen in stage 20 RA-treated embryos corresponds at
east in part to the lateral mesoderm that is initially part
f the heart field but normally loses potency. GATA
actors may therefore represent molecular markers for
he initial heart field, which becomes blocked from
urther development in the RA-treated embryos. Indeed,
ecent cell-ablation experiments in zebrafish support the
ypothesis that GATA-4 expression delineates the
oundary of the heart field. In zebrafish, only the anterior
alf of the Nkx2.5-positive lateral plate mesoderm con-
ributes to the cardiogenic progenitor population. When
ells of the normal cardiogenic region are ablated, more
nterior cells that express GATA-4 acquire a cardiac cell
ate (Serbedzija et al., 1998).
Our data support a model in which the pattern of
ATA factor expression helps determine the boundary of
he cardiac field and the levels are critical to regulating
he normal progression to a differentiated heart. GATA
actors might be required for the activation or mainte-
ance of an Nkx2-dependent cardiac differentiation pro-
ram, but the levels and boundaries must also be con-
rolled to allow restriction of the heart field and permit
erminal differentiation. Therefore (see Fig. 6), overex-
ression of GATA-6 leads to a reduction in the potential
f cells to express a differentiated cardiomyocyte pro-
ram (Gove et al., 1997). According to this model (Fig. 6,
iddle), it might be predicted that overexpression of
ild-type GATA-4 would lead to a reduction in the
xpression domain of Nkx2.5. However, we did not find
his, nor were changes in the Nkx2.5 transcript patterns
etected by GATA-6 overexpression in the study by Gove
t al. (1997). Therefore, GATA factors themselves may
ot be limiting in the control of Nkx2.5 and probably do
ot function alone in this capacity, but downstream of
nd/or in parallel to other genes regulated by RA. In
ontrast, repression of GATA-dependent target genes
using the dominant negative isoform SRG4) leads to an
xpansion of the Nkx2.5 transcript pattern, indicating
hat one or more GATA target genes function normally in
efining the Nkx2.5 pattern and restricting those cells of
he cardiac field that are competent for myocardial devel-
pment. The dominant negative isoform may interfere
ith pathways for each of the GATA-4/5/6 factors,
esulting in a transient depletion of some factor(s) needed
or proper heart patterning. Depletion of any single
ATA factor might not be sufficient to generate a similar
esult. We note that aspects of this mechanism may be
elevant only in vertebrate species that have a regulative
eart field (Ehrman and Yutzey, 1999).
s of reproduction in any form reserved.
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68 Jiang, Drysdale, and EvansGATA Factors Have Multiple Functions in
Cardiovascular Development
From this work we conclude that expression of GATA
factors in precardiac mesoderm is not sufficient to activate
a myocardial differentiation program. Instead, the data
indicate that GATA factor activity may need to be moder-
ated for differentiation to proceed, consistent with the
misexpression experiments using GATA-6 (Gove et al.,
1997) and providing indirect evidence that GATA factors in
heart mesoderm define the boundaries of the cardiac mor-
phogenetic field. This adds to a growing list of experimen-
tally determined functions for GATA factors in the devel-
oping cardiovascular system, including development of
cardiac-associated endoderm (Narita et al., 1997, and our
unpublished results), heart tube formation and morphogen-
esis (Jiang et al., 1998; Kostetskii et al., 1999; Kuo et al.,
1997; Molkentin et al., 1997), cardiomyocyte proliferation
Gove et al., 1997), cardiomyocyte differentiation (Grepin et
l., 1995, 1997), hypertrophic response (Molkentin et al.,
1998), and great vessel smooth muscle cell differentiation
(Mano et al., 1999; Suzuki et al., 1996). In contrast to GATA
FIG. 6. Based on the data presented, we hypothesize that the leve
eart field that will express Nkx2 genes and be competent for
ardiomyocyte differentiation can be repressed. Inhibition of GAT
ranscripts, perhaps providing competence to a larger part of the h
onsistent with additional reports in the literature demonstrating
(Cleaver et al., 1996) to inhibit or expand, respectively, the popu
relatively late effect and neither GATA-4 or GATA-6 overexpressio
Nkx2 expression in the pharyngeal endoderm is not indicated in
expression in the pharyngeal endoderm and also does inhibit Nkxfactors in the hematopoietic system, which appear to con-
trol primarily cell proliferation and differentiation deci-
Copyright © 1999 by Academic Press. All rightions within specific cell lineages, the cardiac-associated
ATA factors function in multiple germ layers, cell types,
nd patterning processes. Defining the target genes for
ATA factors that control patterning and morphogenetic
rograms provides an important future challenge.
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